Skip to main content

Abstract

Insulin-like growth factor I (IGF-I) has been synthesized by recombinant DNA technology (1). With the availability of large quantities of the biosynthetic peptide, the biological effects have been studied in animals in vivo. We have previously reported that IGF-I has growth promoting, anabolic, and insulin-like effects in hypophysectomized and normal rats, and IGF-I inhibits catabolism in fasted rats in vivo (2–5). Recently, the biological effects of IGF-I have been studied in normal men and patients with Laron-type dwarfism (6–9). We have also studied effects of IGF-I single sc administration in normal men (10). In this paper, the results of the single sc administration of IGF-I combined with our previous data (10) are reported.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Niwa M, Sato S, Saito Y, Uchiyama F, Ono H, Yamashita M, Kitaguchi Y, Shiga Y, Notani J, Yamada H, Ishii Y, Ueda I and Takagi Y. Chemical synthesis, cloning, and expression of genes for human somatomedin C (insulin-like growth factor I) and 59Val-somatomedin C. Ann NY Acad Sci 469:31–52 (1986).

    Article  PubMed  CAS  Google Scholar 

  2. Hizuka N, Takano K, Shizume K, Asakawa K, Miyakawa M, Tanaka I and Horikawa R. Insulin-like growth factor I stimulates growth in normal growing rats. Eur J Phamacol 125:U3–U6 (1986).

    Article  Google Scholar 

  3. Hizuka N, Takano K, Asakawa K, Miyakawa M, Tanaka I, Horikawa R, Hasegawa S, Mikasa Y, Saito S, Shibasaki T and Shizume K. In vivo effects of insulin-like growth factor I in rats. Endocrinol Japon 34(Suppl):115–121 (1987).

    Article  CAS  Google Scholar 

  4. Hizuka N, Takano K, Asakawa K, Sukegawa I, Horikawa R, Kikuchi H and Shizume K. Biological action of insulin-like growth factor-I in vivo. In: Bercu BB (ed) Basic and Clinical Aspects of Growth Hormone Plenum Press New York p. 223–231 (1988).

    Google Scholar 

  5. Hizuka N, Takano K, Asakawa K, Shizume K and Kikuchi H. Biological effects of insulin-like growth factor I in vivo. Gunma Symposia on Endocrinology 25:137–U7 (1988).

    CAS  Google Scholar 

  6. Guler H-P, Zapf J and Froesch ER. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 317:137–140 (1987).

    Article  PubMed  CAS  Google Scholar 

  7. Guler H-P, Schmid C, Zapf J and Froesch ER. Effects of recombinant IGF-I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA 86:2868–2872 (1989).

    Article  PubMed  CAS  Google Scholar 

  8. Guler H-P, Eckardt K-U, Zapf J, Bauer C and Froesch ER. Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol 121:101–106 (1989).

    PubMed  CAS  Google Scholar 

  9. Laron Z, Klinger B, Ersner B and Anin S. Effects of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism. Lancet II 1170–1172 (1988).

    Article  Google Scholar 

  10. Takano K, Hizuka N, Asakawa K, Sukegawa I, Shizume K and Demura H. Effects of sc administration of recombinant human insulin-like growth factor I (IGF-I) on normal human subjects. Endocrinol Japon 37:309–317 (1990)

    Article  CAS  Google Scholar 

  11. Miyakawa M, Hizuka N, Takano K, Tanaka I, Horikawa R, Honda N and Shizume K. Radioimmunoassay for insulin-like growth factor I (IGF-I) using biosynthetic IGF-I. Endocrinol Japon 33:795–801 (1986).

    Article  CAS  Google Scholar 

  12. Daughaday WH, Mariz IK and Blethen SK. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab 51:781–788 (1980).

    Article  PubMed  CAS  Google Scholar 

  13. Hizuka N, Takano K, Asakawa K, Sukegawa I, Fukuda I, Demura H, Iwashita M, Adachi T and Shizume K. Measurement of free form of insulin-like growth factor I in human plasma. Growth Regulation submitted.

    Google Scholar 

  14. Asakawa K, Hizuka N, Takano K, Fukuda I, Sukegawa I, Demura H and Shizume K Radioimmunoassay for insulin-like growth factor II (IGF-II). Endocrinol Japon 37:in press (1990).

    Google Scholar 

  15. Sukegawa I, Hizuka N, Takano K, Asakawa K, Horikawa R, Hashida S, Ishikawa E, Mohri Z, Murakami Y and Shizume K. Urinary growth hormone (GH) measurements are useful for evaluating endogenous GH secretion. J Clin Endocrinol Metab 66:1119–1123 (1988).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Plenum Press, New York

About this chapter

Cite this chapter

Hizuka, N. et al. (1991). Single sc Administration of Insulin-Like Growth Factor I (IGF-I) in Normal Men. In: Raizada, M.K., LeRoith, D. (eds) Molecular Biology and Physiology of Insulin and Insulin-Like Growth Factors. Advances in Experimental Medicine and Biology, vol 293. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5949-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5949-4_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5951-7

  • Online ISBN: 978-1-4684-5949-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics